Investment firm takes stake in NTU spin-out

Braveheart, the fund management and investment group, has bought a 33% stake in Pharm2Farm (P2F).

P2F is a spin-out from Nottingham Trent University (NTU) and is based in Nottingham.

NTU and P2F have developed and patented a process to increase the bioavailability of trace minerals in plant feeds. Its patented process uses nanotechnology to improve trace element take-up in both flower and crop farming. P2F produces and sell these products through an exclusive licence to this technology from NTU.

The Board of Braveheart believes there is a “substantial market opportunity” for this technology and is in negotiations to take the Group’s shareholding in P2F to 54% by way of a working capital investment.